Literature DB >> 16132289

Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium.

A F Freeman1, S E Crawford, M L Cornwall, F L Garcia, S T Shulman, A H Rowley.   

Abstract

Angiogenesis has been shown to be dysregulated in coronary artery (CA) aneurysms in the chronic phase of Kawasaki disease (KD). Neovascularization may occur in inflammatory-related vascular diseases because many angiogenesis mediators are secreted by inflammatory cells. We hypothesized that inflammation of the acute KD CA aneurysm could lead to dysregulation of angiogenesis mediators and subsequent neovascularization. To investigate this hypothesis, acute fatal KD cardiac tissues were immunostained for angiogenic inducers and inhibitors. Microvessel density was determined and the degree of inflammation assessed. Marked inflammation and angiogenesis were found in acute KD CA aneurysms and myocardium, with the highest microvessel density seen in patients who died 2-3 weeks after onset of the disease. Expression of proangiogenic proteins was higher than expression of inhibitors in KD CA aneurysms and myocardium. Angiogenesis mediators were localized to inflammatory cells in the myointima, adventitia, and myocardium. We conclude that significant neovascularization occurs in acute KD CA aneurysms and myocardium much sooner after onset of the disease than has been previously reported, that multiple angiogenesis factors are involved, and that dysregulation of angiogenesis likely contributes to KD vasculopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16132289     DOI: 10.1007/s00246-005-0801-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  31 in total

1.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen prolongs the life span of primary human umbilical vein endothelial cells.

Authors:  Takahiro Watanabe; Makoto Sugaya; April M Atkins; Elisabeth A Aquilino; Aparche Yang; Debra L Borris; John Brady; Andrew Blauvelt
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 2.  Angiogenesis: models and modulators.

Authors:  G W Cockerill; J R Gamble; M A Vadas
Journal:  Int Rev Cytol       Date:  1995

3.  The hepatitis C virus internal ribosome entry site facilitates efficient protein synthesis in blood vessel endothelium during tumour angiogenesis.

Authors:  Grace T Y Chung; Yoshihiro Yamada; Richard Pannell; Alan Forster; Terence H Rabbitts
Journal:  Nucleic Acids Res       Date:  2003-04-15       Impact factor: 16.971

4.  Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels.

Authors:  F Falcini; M M Cerinic; M Ermini; S Generini; A Lombardi; A Pignone; G Leoncini; P Tirassa; L Aloe
Journal:  J Rheumatol       Date:  1996-10       Impact factor: 4.666

5.  Vascular endothelial growth factor in acute Kawasaki disease.

Authors:  M Terai; K Yasukawa; S Narumoto; S Tateno; S Oana; Y Kohno
Journal:  Am J Cardiol       Date:  1999-02-01       Impact factor: 2.778

6.  Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study.

Authors:  A Suzuki; S Miyagawa-Tomita; K Komatsu; T Nishikawa; Y Sakomura; T Horie; M Nakazawa
Journal:  Circulation       Date:  2000-06-27       Impact factor: 29.690

7.  Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease.

Authors:  Kumi Yasukawa; Masaru Terai; Stanford T Shulman; Tetsuya Toyozaki; Shigehiro Yajima; Yoichi Kohno; Anne H Rowley
Journal:  Circulation       Date:  2002-02-12       Impact factor: 29.690

8.  Nerve growth factor production by lymphocytes.

Authors:  L Santambrogio; M Benedetti; M V Chao; R Muzaffar; K Kulig; N Gabellini; G Hochwald
Journal:  J Immunol       Date:  1994-11-15       Impact factor: 5.422

9.  Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes.

Authors:  P J Mansfield; S J Suchard
Journal:  J Immunol       Date:  1994-11-01       Impact factor: 5.422

10.  Increased serum levels of vascular endothelial growth factor in Kawasaki disease.

Authors:  N Maeno; S Takei; K Masuda; H Akaike; K Matsuo; I Kitajima; I Maruyama; K Miyata
Journal:  Pediatr Res       Date:  1998-10       Impact factor: 3.756

View more
  8 in total

1.  Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance.

Authors:  Wen Fury; Adriana H Tremoulet; Virginia E Watson; Brookie M Best; Chisato Shimizu; Jennifer Hamilton; John T Kanegaye; Yi Wei; Chiayi Kao; Scott Mellis; Calvin Lin; Jane C Burns
Journal:  Hum Immunol       Date:  2010-06-20       Impact factor: 2.850

2.  Interleukin-18 gene 105A/C genetic polymorphism is associated with the susceptibility of Kawasaki disease.

Authors:  Shih-Yin Chen; Lei Wan; Yu-Chuen Huang; Jim Jinn-Chyuan Sheu; Yu-Ching Lan; Chih-Ho Lai; Cheng-Wen Lin; Jeng Sheng Chang; Yuhsin Tsai; Shih-Ping Liu; Ying-Ju Lin; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

3.  IL-1-dependent electrophysiological changes and cardiac neural remodeling in a mouse model of Kawasaki disease vasculitis.

Authors:  M Abe; D D Rastelli; A C Gomez; E Cingolani; Y Lee; P R Soni; M C Fishbein; T J A Lehman; K Shimada; T R Crother; S Chen; M Noval Rivas; M Arditi
Journal:  Clin Exp Immunol       Date:  2019-12-09       Impact factor: 4.330

Review 4.  Pathogenesis and management of Kawasaki disease.

Authors:  Anne H Rowley; Stanford T Shulman
Journal:  Expert Rev Anti Infect Ther       Date:  2010-02       Impact factor: 5.091

5.  Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey.

Authors:  Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Atsuko Sadakane; Izumi Chihara; Yasuko Aoyama; Kazuhiko Kotani; Hiroshi Yanagawa
Journal:  J Epidemiol       Date:  2010-06-05       Impact factor: 3.211

6.  Case Report: Structural Changes in the Coronary Vessel Wall in a Patient With Incomplete Kawasaki Disease.

Authors:  Takamichi Ishikawa; Hiroki Uchiyama; Satoshi Mogi; Hayato Ohtani
Journal:  Front Pediatr       Date:  2022-03-03       Impact factor: 3.418

7.  Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006.

Authors:  Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Izumi Oki; Makoto Watanabe; Hiroshi Yanagawa
Journal:  J Epidemiol       Date:  2008-07-18       Impact factor: 3.211

Review 8.  Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight.

Authors:  Anne H Rowley; Susan C Baker; Jan M Orenstein; Stanford T Shulman
Journal:  Nat Rev Microbiol       Date:  2008-05       Impact factor: 60.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.